Abstract:Background. Follicular helper T (Tfh) cells are critical for high-affinity antibody generation and B cell maturation and differentiation, which play important roles in autoimmune diseases. Graves’ disease (GD) is one prototype of common organ-specific autoimmune thyroid diseases (AITD) characterized by autoreactive antibodies, suggesting a possible role for Tfh cells in the pathogenesis of GD. Our objective was to explore the role of circulating Tfh cell subsets and associated plasma cells (PCs) in patients with GD. Methods. Thirty-six patients with GD and 20 healthy controls (HC) were enrolled in this study. The frequencies of circulating Tfh cell subsets and PCs were determined by flow cytometry, and plasma cytokines, including interleukin- (IL-) 21, IL-4, IL-17A, and interferon- (IFN-) γ, were measured using an enzyme-linked immunosorbent assay (ELISA). The mRNA expression of transcription factors (Bcl-6, T-bet, GATA-3, and RORγt) in peripheral blood mononuclear cells (PBMCs) was evaluated by real-time quantitative PCR. Results. Compared with HC, the frequencies of circulating CD4+CXCR5+CD45RA−Tfh (cTfh) cells with ICOS and PD-1 expression, the Tfh2 subset (CXCR3−CCR6−Tfh) cells, and PCs (CD19+CD27highCD38high) were significantly increased in the GD patients, but the frequencies of Tfh1 (CXCR3+CCR6−Tfh) and Tfh17 (CXCR3−CCR6+Tfh) subset cells among CD4+T cells were significantly decreased in GD patients. The plasma concentrations of IL-21, IL-4, and IL-17A were elevated in GD patients. Additionally, a positive correlation was found between the frequency of PD-1+Tfh cells (Tfh2 or PCs) and plasma IL-21 concentration (or serum TPO-Ab levels). The mRNA levels of transcription factors (GATA-3 and RORγt) were significantly increased, but T-bet and Bcl-6 mRNA expression was not obviously varied in PBMCs from GD patients. Interestingly, Tfh cell subsets and PCs from GD patients were partly normalized by treatment. Conclusion. Circulating Tfh cell subsets and PCs might play an important role in the pathogenesis of GD, which are potential clues for GD patients’ interventions.

The increased but non-predominant expression of Th17- and Th1-specific cytokines in Hashimoto's thyroiditis but not in Graves' disease.

Increased IL-21/IL-21R Expression and Its Proinflammatory Effects in Autoimmune Thyroid Disease.

Different Levels of Circulating Th22 Cell and Its Related Molecules in Graves' Disease and Hashimoto's Thyroiditis.

Increased Differentiation of Th22 Cells in Hashimoto's Thyroiditis.

Impairment of Regulatory Capacity of Cd4(+)Cd25(+) Regulatory T Cells Mediated by Dendritic Cell Polarization and Hyperthyroidism in Graves' Disease

A High Frequency Of Circulating Th22 And Th17 Cells In Patients With New Onset Graves' Disease

Increased Proportions of Tc17 Cells and NK Cells May Be Risk Factors for Disease Progression in Hashimoto's Thyroiditis.

Thyroid Antibodies in Hashimoto’s Thyroiditis Patients Are Positively Associated with Inflammation and Multiple Symptoms

Constitutive Changes in Circulating Follicular Helper T Cells and Their Subsets in Patients with Graves’ Disease

The imbalance between Th17 and CD4+ CD25+ regulatory T cells in patients with Hashimoto's thyroiditis

Expression of IFNα-inducible Genes and Modulation of HLA-DR and Thyroid Stimulating Hormone Receptors in Graves’ Disease

A Higher Frequency of Circulating IL-22(+)CD4(+) T Cells in Chinese Patients with Newly Diagnosed Hashimoto's Thyroiditis.

High-throughput T cell receptor sequencing reveals differential immune repertoires in autoimmune thyroid diseases

[The Role of Th17 Cells and IL-17 in Hashimoto's Thyroiditis: Review].

Elevated Follicular Helper T Cells and Expression of IL-21 in Thyroid Tissues Are Involved in the Pathogenesis of Graves' Disease.

Th17 Cell Plays a Role in the Pathogenesis of Hashimoto's Thyroiditis in Patients.

Thyrocyte Interleukin‐18 Expression is Up‐regulated by Interferon‐γ and May Contribute to Thyroid Destruction in Hashimoto’s Thyroiditis

Expression of Foxp3 in Peripheral Blood and Lesion Tissues of Patients with Autoimmune Thyroid Disease

Evaluation of IL-10, MCP-1, IFN gamma, and protectin D1 levels in patients with Hashimoto's thyroiditis

Increased interleukin-9 and Th9 cells in patients with refractory Graves’ disease and interleukin-9 polymorphisms are associated with autoimmune thyroid diseases

Detection and significance of the alteration of Th17 cells in patients with Hashimoto's thyroiditis and Graves' disease